News
Meet CILcare-CBSET at the Safety Pharmacology Society annual meeting in Brussels
This year, CILcare is exhibiting with its US partner CBSET at the annual meeting of the Safety Pharmacology Society in Brussels, Belgium on September 18-21. Come to our booth #506 to learn more about our ototoxicity services and our expertise in in vitro, ex vivo, and...
CILcare to attend the IEB in London and give a presentation on cochlear synaptopathy preclinical and clinical research at the Hearing Therapeutics Summit
58th Inner Ear Biology workshop CILcare is glad to announce that its R&D team will be attending the 58th Inner Ear Biology workshop in London, UK, on September 3-5, 2023, hosted by the UCL Ear Institute. This year the event will focus on the genetics, pathology...
CILcare featured in EACCNY’s “Future of Technology” podcast
The sixth episode of the fourth season of the Future of Technology podcast, presented by the European American Chamber of Commerce of New-York in collaboration with CILcare, brings you an insightful discussion with Dr. Keith Darrow, a distinguished member of CILcare's...
CILcare announces appointment of Alain Chatelin, acting as Chief Medical Officer
Montpellier - France – July 10th, 2023 – CILcare, a biotechnology company specialized in auditory sciences and research and development of new therapies for inner ear and associated diseases, is announcing the appointment of Alain Chatelin acting as Chief Medical...
New milestone achieved by CILcare to demonstrate the importance of auditory signatures as new marker of neuro-inflammatory diseases
CILcare has achieved a novel milestone by starting patient recruitment in their DIAMANT trial, the first clinical study aiming to deepen knowledge of the link between diabetes and hearing pathologies: First observational clinical study conducted at the IDNC (Institute...
CILcare won FACCNE’s 2023 Women in Business award!
CILcare’s team is honored to have been awarded by the French-American Chamber of New England (FACCNE) in the Women in Business category. The French-American Business Awards took place during FACCNE's annual gala, which has been celebrating for over 20 years the best...
CILcare announces the launch of the OrgaEar project with SATT AxLR and the University of Montpellier
Sylvie PUCHEU, CILcare’s Chief Scientific Officer and Philippe NERIN, SATT AxLR’s PresidentMontpellier - France – May 17th, 2023 – CILcare, a company specialized in the research and development of new therapies for auditory pathologies, and SATT AxLR are launching the...
CILCARE NOMINATED BY FACCNE FOR WOMEN IN BUSINESS AWARD 2023 !
CILcare’s team is honored and delighted to be part of the nominees for Women in Business Award by the French-American Chamber of New England (FACCNE). In one night only, FACCNE groups its Annual Gala and Awards Ceremony to recognize Excellence, Innovation and...
